dbo:abstract
|
- جوان إي. بيرغر- سويني، عالمة أعصاب أمريكية والرئيس الثاني والعشرين لكلية الثالوث، في هارتفورد في كونيتيكت. (ar)
- Joanne E. Berger-Sweeney (born September 21, 1958) is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut. She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine (brand name Razadyne), the second-most used drug to treat Alzheimer's disease. (en)
|
dbo:academicDiscipline
| |
dbo:award
| |
dbo:birthDate
| |
dbo:birthName
| |
dbo:birthPlace
| |
dbo:doctoralAdvisor
| |
dbo:doctoralStudent
| |
dbo:institution
| |
dbo:knownFor
| |
dbo:thumbnail
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 19873 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:after
| |
dbp:alt
|
- Joanne Berger-Sweeney in 2012 (en)
|
dbp:awards
|
- Alumni Achievement Award, Johns Hopkins University (en)
- Posse Star, Posse Foundation (en)
|
dbp:before
| |
dbp:birthDate
| |
dbp:birthName
| |
dbp:birthPlace
|
- Los Angeles, California (en)
|
dbp:caption
|
- Joanne Berger-Sweeney in 2012 (en)
|
dbp:children
| |
dbp:doctoralAdvisor
| |
dbp:doctoralStudents
| |
dbp:education
| |
dbp:fields
| |
dbp:knownFor
|
- Proof-of-concept work on galantamine, a drug used to treat Alzheimer's disease (en)
|
dbp:name
|
- Joanne Berger-Sweeney (en)
|
dbp:nationality
| |
dbp:signature
|
- Joanne_Berger-Sweeney_Signature.png (en)
|
dbp:spouse
| |
dbp:title
| |
dbp:wikiPageUsesTemplate
| |
dbp:workplaces
| |
dbp:years
| |
dcterms:subject
| |
rdf:type
| |
rdfs:comment
|
- جوان إي. بيرغر- سويني، عالمة أعصاب أمريكية والرئيس الثاني والعشرين لكلية الثالوث، في هارتفورد في كونيتيكت. (ar)
- Joanne E. Berger-Sweeney (born September 21, 1958) is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut. She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine (brand name Razadyne), the second-most used drug to treat Alzheimer's disease. (en)
|
rdfs:label
|
- جوان بيرغر-سويني (ar)
- Joanne Berger-Sweeney (en)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:homepage
| |
foaf:isPrimaryTopicOf
| |
foaf:name
|
- Joanne Berger-Sweeney (en)
|
is dbo:president
of | |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is dbp:president
of | |
is foaf:primaryTopic
of | |